Login

Kadans Buys Another King's Cross Life Sciences Development Opportunity

Group Now Has 350,000 Square Feet of Lab Space Coming Forward in London Knowledge Quarter
22-23 Tileyard Road plans. (Kadans)
22-23 Tileyard Road plans. (Kadans)
CoStar News
December 18, 2023 | 10:56 AM

Kadans Science Partner, the AXA IM Alts-owned life sciences group, has bought another building in King’s Cross in London, this time 22-23 Tileyard Road from City and Provincial.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In